Comments on: Business must change to earn back the public’s trust http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/ Thu, 21 Jul 2016 07:57:19 +0000 hourly 1 http://wordpress.org/?v=4.2.5 By: RichardBaum http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29746 Thu, 08 Apr 2010 16:32:06 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29746 Thanks for your questions. Jeff Kindler has responded to a selection of them here: http://blogs.reuters.com/great-debate/20 10/04/08/pfizer-ceo-responds-to-your-que stions/

]]>
By: donjohn http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29534 Fri, 26 Mar 2010 00:07:47 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29534 Mr. Kindler, as you may already know, the recent health care reform legislation will end up benefitting the health insurance companies and drug makers like yourself. Nothing wrong with that. It only puts more pressure on you to realize your expressed intention to realy provide true healthcare to us ordinary folks.In this regard, you must also know the recent health care legislations will only influence the health insurance industry and not the provision of healthcare itself.

To do your part you must move beyond what your company does and what your shareholders expect of you. You must set benchmarks beyond just being a pharmaceutical company. I suggest you use the impending increase in your revenue to diversify your company’s portfolio into other aspects of healthcare. A good start will be the establishing of a network of non-profit or No-Frills hospitals and centers for primary care. This will help reverse the profit orientation of current private hospitals through their ridiculous construction of 5-Star hospitals that rival luxury resorts, catering for rich and sick people.( Do you really notice the piped in sound of bird songs amidst gushing fountains when you are lieing in your sick bed recovering from your heart surgery? These luxury hospitals are like expensive funeral parlors. They provide services that can only be appreciated by the relatives and friends of the dead and dying.) Unfortunately,they have set the standard of greed in the healthcare industry.

]]>
By: Ghandiolfini http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29492 Mon, 22 Mar 2010 19:27:53 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29492 solarae: Morals = the juristic person, ethics = society.

Jeff, this is all about numbers and money. Please could we have feedback on cancer research and the % of your R&D and for that matter, of the Health Bill and all the drama surrounding it.

Is it curable or are we chasing our tails and do we throw in the towel ? I know it is about quality of life etc. but that is talk, ultimately we will all hang on to dear life,is there a way to make it more ‘pleasant’ ?

]]>
By: MPetersen http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29480 Mon, 22 Mar 2010 12:46:30 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29480 Hi Jeff, firstly well done on the transparency I think this is really marking the start of a new era within business in particular pharma which is still struggling at times in engaging their patient consumer base.

I agree with your points on counterfeit drugs Jeff, unfortunately these tend to be a problem in 3rd world countries where money and education is not readily available for innovator or even generic alternatives. I realise that companies like Pfizer, Novartis, AZ, Novonordisk and Sanofi etc have set up some amazing programmes in Africa & Asia which should in no way be downplayed. But counterfeiting is a massive problem what can we all be doing to stop this problem?, do you feel pharma as a whole are making free drugs more readily available in these counterfeit hotspots to bring down the price of drugs as a whole? And are there enough outreach programmes to educate isolated communities on the dangers (or lack of effect) of counterfeit drugs as well as the diseases these drugs will treat. Is enough being spent? What are your thoughts on this.

Many thanks for your time and your candid interview.

Michelle Petersen

]]>
By: refreshesdotcom http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29479 Mon, 22 Mar 2010 11:52:58 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29479 Given the PR issues are there any initiatives underway to rebrand? For example: http;//Refreshes.com

]]>
By: rajp http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29405 Thu, 18 Mar 2010 16:15:33 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29405 Hi Mr. Kindler, I understand that you are trying to reduce costs of R&D but maintain the same level of research done within your company. Have you looked at open innovation where you could partner with other research firms to accelerate your drug development? I know that Sanofi and Merck are converging to that model where partnerships are going to be important in future research.

]]>
By: mok http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29404 Thu, 18 Mar 2010 10:27:08 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29404 Mr. Kindler. I applaud you willingness to take questions. The problem here is that between management and investors, nobody cares about anything other than money. If a company does “the right thing” it’s because they have to, or because they were caught with their pants down. There is nothing wrong with profit. It just shouldn’t be higher on the priority list than actually caring about people.

Can you give an example of any time your company, or any company for that matter, has ever TRULY gone against the bottom line to do what is right?

PS: Your giving away zithromax is very commendable, but I don’t count that. It’s a very low cost drug, and giving it away was a great PR move and probably costs less than a good ad campaign. Ever give anything really expensive away?

]]>
By: Rambler http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29403 Thu, 18 Mar 2010 09:25:17 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29403 With patent protections going soon isn’t the sudden focus on generic drugs as much out of necessity than a conscious corporate decision? But with patent protections going how much would R&D be affected at a big company like Pfizer?

]]>
By: gramps http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29402 Thu, 18 Mar 2010 06:04:28 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29402 Hi, Mr. Kindler Question -are you willing to see that Pfizer opts out of protection as a “person” under the first amendment ? Bet you won’t.

]]>
By: PMoon http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/#comment-29400 Wed, 17 Mar 2010 20:00:38 +0000 http://blogs.reuters.com/great-debate/?p=6757#comment-29400 ” People can go to the Web to see how we compensate doctors outside our company”

1) This was mandated by a court settlement, was it not? It seems that this, and other regulatory measures mandated by court settlement, are overseen by Pfizer officials. Do you feel these court mandated, but self-supervised, measures add to the distrust your company faces?

2) By mention of these court mandated actions taken, you seem to imply a sense of pride in them and their ability to rebuild consumer trust. Does this mean you would be willing to cooperate in further court and/or government regulation?

Thank you and I look forward to your answers.
P. Moon

]]>